As of 2024-12-13, the Fair Value of N4 Pharma PLC (N4P.L) is -1.20 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.60 GBP, the upside of N4 Pharma PLC is -300.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.88 | -1.30 | -1.54 | -1.03 | -1.28 | -1.21 |
| YoY growth | 26.03% | -48.89% | -18.36% | 33.35% | -24.05% | -6.38% |
| Market Cap (mil) | 2.80 |
| P/E | |
| Forward P/E |
| EPS | -0.24 |
| Avg earnings growth rate | -6.38% |
| TTM earnings | -1.12 |